The conversion o f lanosterol into ergosterol, the main sterol in most pathogenic yeasts and fungi, is a complex multistep process, catalysed by enzymes in the mitochondria and endoplasmic reticulum [ I ] . A key step in this segment of the sterol biosynthetic pathway is the cytochrome P 4 5 0 (P450)-dependent removal of the methyl group (C-32) at C-14.
Alexander el u/. 121 first assumed the involvement of a P450 in the conversion of lanosterol into zymosterol during ergosterol biosynthesis. Ohba et ul. [ 3 J showed that this 14a-demethylation of lanosterol is NADPH-and oxygendependent and that the 140-demethylation step is inhibited by antibodies to P450 reductase. These observations led the authors to conclude that in Succharotnyces cerevisiue microsomes, P450 (P450-dependent 14a-demethylase; P450,,l,M) is involved in the oxidative removal of C-32 (the l4a-methyl group) of lanosterol. P4S0,,,,, has been purified to homogeneity from S. cerevisiue microsomes [4] and it has been proven that this P450 catalyses the three oxidative steps involved in the 14a-demethylation of lanosterol.
The amino acid sequences of the S. cerevisiue [S, 61, Cundida albicuns [7] and Cundidu tropicalis (81 P450,,[) albicuns) and 81.1% (C. iropiculis), thus the three P450,,,,r are orthologous forms of the P450LIA1 gene (nomenclature according to Nebert et ul. [9] ). The P45ol4,,, from C. ufbicurts and C'. tropicalis even share 83% identical and 10% [ 14, 1 S ] also proved that ketoconazole inhibits lanosterol 14a-demethylation by a reconstituted system consisting of P450,,"M and NADPH-P450 reductase, both purified from S. cerevisiae microsomes. Complete inhibition by ketoconazole is achieved at the concentration which is equivalent to the P45ol,[,M concentration, i.e. 1.4 x lo-' M. Ketoconazole does not inhibit NADPHcytochrome c reductase activity catalysed by the P450 reductase. These results, together with the fact that ketoconazole and other imidazole and triazole derivatives induce marked spectral changes of the purified P450,,,,,, prove that these azole derivatives inhibit the 14a-demethylation by a direct effect on the P450,,,,M [ 131.
The effect of azole antifungals on the P450-dependent ergosterol synthesis has been proven in many yeasts and fungi. Examples are C. ulbicuris, C'. hcsituniue, Aspergillirs spp. and I'etzicillitrm spp. (16, 171 . Recently, we were able to prove that both ketoconazole and itraconazole inhibit ergosterol synthesis in Ifistoplusmu cupsitkatum (yeast form). Depletion of ergosterol is already achieved after 48 h of growth in the presence of lo-' M-ketoconazole and 3 X lo-' M-itraconazole (H. Vanden Bossche, unpublished work). As can be expected from the above discussed interaction of azole antifungals with P450,,,,,, inhibition of crgosterol synthesis coincided with the accumulation of sterols with a methyl group at C-14. Examples are 14-methyl-AK. 24(2xJ-crgosta-diene-3,9, 6a-diol, 14-methylfecosterol, 14-methylfecosterone. 14-meth~1-A~-' . ". ?''" -ergosta-tetraene-3P-ol, cxbtusifoliol. obtusifolione. 24-methylenedihydrolanosterol and lanostcrol.
Resisturice to azole atitifittigals
Yoshida et ul. 1181 purified a P450 (P450,,,,) from a nystatin-resistant mutant, S. cerevisiae SG,, which is defective in lanosterol 14a-demethylation. A single nucleotide change resulting in substitution of aspartic acid for glycine-310 of P4501J,,M was found to have occurred in P450,,, [6] . In this protein the 6th ligand to the haem iron is a histidine residue 161 instead of the hydroxyl group of water or of a serine, tyrosine or threonine residue, which is the most likely candidate for the 6th ligand in normal P450s. This P450,,, not only lost its catalytic activity, but also did not interact with the pyridyl antifungal, buthiobate [ 191. Hence, the field strength of the native sixth ligand (histidine) is stronger than that of pyridine. This S. cerevisiae mutant is also less sensitive to ketoconazole and itraconazole. The concentration producing 50% inhibition (IC5,,) of growth (24 h cultures) was 2 x l o -? M-ketoconazole, whereas, with the parent strain (D587), this inhibition was already achieved at 7 x lo-' M. ltraconazole did not affect growth of SG, at concentrations up to 5 x l W h M (i.e. at the limit of solubility). The IC,,, value for the growth of strain D587 was 1.9 x To measure the affinity of ketoconazole and itraconazole for the microsomal P4SOs of both the parent strain (DS87) and of the SG, mutant, increasing concentrations (up to M.
Fable I . Effects of' u z d e rrtirifirngu1.s o t i the formutiori of the reduced ('0-P450 complexes
The method is described in [ 121. P450 content: 0.1 nmol/ml. (SG,) and 449 nm (DS87).The P45OSc,,-itraconazole complex is less stable than that formed with the microsoma1 P45O(s) of the parent strain. However. as can be deduced from the gradual spectral changc (Fig. I) . the P450,,,-ketoconazole complex is almost completely replaced by a P450-CO complex. The complex of ketoconazole with the microsomal P4SO of the parent strain was more difficult to replace, but was still more easily replaced than that o f itraconazolc. Similar results were obtained with azolesensitive C. albicarzs isolates [ 12, 201. These results suggest. that in contrast with the pyridine derivative, these imidazole and triazole derivatives can replace histidine from its binding place, i.e. the 6th co-ordination position o f the haem iron. It has been suggested that nitrogen heterocycles with large hydrophobic N-1 substitucnts not only bind to the haem iron but also interact with the apoprotein [ 131. Since both azole antifungals can be more easily replaced by CO from thc 6th co-ordination position of P450,,i,, it is tempting to speculate that the affinity of these azoles for thc apoprotein of this The results discussed here suggest that the antifungal activity of the azole derivatives depends on the sensitivity of P 4 5 h~.
Since the introduction of azole antifungals in 1971 only four cases of 'azole resistance' in C. ulbicans have been reported. C'. albicuns isolate S H (B41628) was obtained from a patient with chronic mucocutaneous candidosis, who relapsed after prolonged treatment with ketoconazole [22] . This isolate was less pathogenic than other C. albicans isolates in a number of animal models of infection [22] . For example, the C. albicuns isolate B41628 might be regarded as non-pathogenic in the vaginal candidosis model in rats 1221. This might suggest that this C. ulbicatis isolate is able to grow in immunocompromised patients only.
lnvestigations are in progress in an attempt to establish the mechanism of resistance of this C. albicutn isolate to azole antifungals. Spectrophotometric studies show that the reduced CO-P450 complex(es) from the microsomal fraction of the ketoconazole-resistant C. albicans iso1L.e (B41628) has maximum absorption at 450 nm instead of 448 nm (maximum absorption found with other C. ulbicuns isolates). This P450( s) shows low affinity for ketoconazole and fluconazole, but still relatively high affinity for itraconazole (Table 1 ). This reduction in binding is decreased when this isolate is subcultured in a drug-free medium. The microsomal P450 from a new isolate (B44548) obtained from this patient after therapy with azole antifungals was stopped, also showed a much higher affinity for azole antifungals compared with isolate B41628 (Table I ) . Both results indicate that the resistance to ketoconazole is reversible.
In an attempt to induce resistance again, isolate B44548 was subcultured in a ketoconazole-containing medium [casein hydrolysate/yeast extract/glucose ( 5 g of each per litrc; CYG-medium) supplemented with lo-'' M-ketoconazole]. After 148 passages (K-148) a slightly lower sensitivity to ketoconazole and fluconazole was again noted (Table 1 ). The long time needed to obtain lower sensitivity indicates that it is difficult to induce resistance against azoles in C' . alhicans. The reduced CO-P450 complex of the same isolate subcultured in drug-free medium (CYG medium supplemented with the solvent, DMSO), shows after 148 passages (C-148) maximum absorption at 448.5 nm. The microsomal P450(s) of this isolate has the same sensitivity to the three azoles as B44548 ( Table I ) .
The lower affinity of the azoles for the microsomal P45O(s) of isolate K-148 was further proven by studying the reactivity of the reduced P450 azole complexes with CO (the method is given in [ 12, 2 I]). Addition of increasing concentrations of ketoconazole or itraconazole to the microsomal suspensions containing P450 isoenzymes in their oxidized state caused type II spectra. The controls contained the same concentration of solvent (DMSO). Upon addition of the rcductant, dithionite, and saturation with CO, a spectrum with an absorption peak at 448.5 nrn (C-148) or 440.5 nm (K-148) was obtained. These reduced CO-complexes were stable over the 45 min measurement period (Fig. 2) . When the microsomal suspension of c'. albicuris C-148 was titrated with itraconazole (up to 5 X lo-" M ) or ketoconazole (up to l o -' M ) and then reduced and gassed with CO, a change in absorption (AA =A4,, nm -A4,,, ,,,,) of 0.007 was found.
With ketoconazole a gradual spectral change was observed during the measurement period (Fig. 2) . This change represents a partial replacement of ketoconazole by CO, similar to Fig. 2 . Dala raker1 from difference .spectru obttiined wilh microsomal prepurutions of C'. ulbicatrs A44548 C -148 (-) or C. alhicuris A44548 K-148 (---) Further details are given in the legend to Fig. 1 . The differences in absorption at 448.5 nm (B44548 C-148) or 449.5 nm (B44548 K-148) and 490 nm are plotted against time. 0 , DMSO; 0, itraconazole; w, ketoconazole.
the displacement seen with azole-sensitive C'. ulbicatis isolates [ 12,2 11 and S. cerevisiur (Fig. 1) . Much morc stable itraconazole-P450 complexes were obtained with microsomal suspensions of both C. ulbicaris C-148 and K-148 (Fig. 2) . However, the ketoconazole-P450 complex obtained with microsomes from C. ulhic~uris K-148 was more easily replaced by a CO-P450 complex (Fig. 2) . The results obtained with K-148 resemble in some way those obtained with P450,,, (Fig. 1 ) and might suggest that the apoprotein of this C. ulbicuru P4.50 is also altered in a region affecting the conformation of the haem environment. The less stable complex formed with ketoconazole and the microsomal P450(s) of C'. albicuris K-148 corresponds very well with its low effect on sterol synthesis by intact cells of the latter isolate (before inoculation in the test media cells were grown 24 h in drug-free CYG-medium). An lC,,, value of 2.2 x M was obtained with K-148, whereas for ergosterol synthesis by C-148 the IC,,, was 9.2 X 10 -' M-ketoconazole. As could be expected from the affinity studics, itraconazole is a much morc potent inhibitor of ergosterol synthesis in both K-148 and C-I 48. IC,,, values of 3.2 x 10 M and 1.75 x 1 W X M are found, respectively. ltraconazole also has a greater effect on the growth of C'. ulbicuris B44548 K-148 and C-148. IC,,, values were 9 x lo-' M and 4.1 X lo-' M, respectively. With ketoconazole, IC,,, values of 3.6 x 10 -" M (K-148) and 1.6 x 10 ~ ' M (C-148) were found. Fluconazole had n o effect on €344548 K-148; 36% inhibition of growth was reached at 1 0 -5 M with Further studies are in progress to establish the exact mechanism of resistance of this C'. ulbicaris isolate. Thew studies may be o f help to prove further the hypothesis that binding of the hydrophobic N-1 substituent of the azoles to the apoprotein of the P450,,,,M plays a key role in their antifungal activity. It may also improve our knowledgc of P4.50,,,,M, one of the most important targets for present antifungals of use in medicine as well as in plant protection.
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Inhibition of the sterol A"'-reductase and A 8 -t A'-isomerase in fungi
Inrrodircriori
Several groups of chemically different compounds have shown to interfere with specific sites in sterol biosynthesis of plant and human pathogenic fungi [ 1-31. Besides C-14 demethylation and squalene epoxidation, two other important sites in sterol biosynthesis have now been identified as targets for fungicides, namely the A "-reductase and the Ax -A'-isomerase.
Groups of chemicals inhibiting the A "-reductase and A n + A7-isomerase comprise the cyclic amines 14-61, azasteroids 131 and the azadecalins 17). T h e cyclic amines are represented by the morpholincs and piperidines. Of the morpholines, tridemorph, fenpropimorph and amorolfine are the most important representatives, whereas of the piperidines it is fenpropidin. Of the azasteroids only the antibiotic A25822B and of the azadecalins only Nsubstituted-8-azadecalins are o f interest with regard to inhibition of the AI"-reductase and/or AX + A'-isomerase.
Recently, another piperidinc has been added to the list of AIJ-reductase and/or AX -A7-isomerase inhibitors [8] . It is an agricultural fungicide, which has been around for about 20 years, called piperalin [ 3-( 2-methylpiperidine)propy1-3,4-dichlorobenzoatel. T h e structural similarities t o the cyclic amines are evident.
lnhibition of the A '"-reductase and Ax -A7-isomerase has been indicated by the accumulation of sterol intermediates and. for some inhibitors, confirmed in assays using the enzymes present in microsomal fractions [ 91. Inhibition of the A'"-reductase and/or Ax -A7-isomerase leads to alteration of the membrane composition. A s a consequence an irregular deposition of chitin is observed. Based on this observation differences in effects on the morphology of budding and filamentous fungi can be explained as wcll as the preferential inhibition of the yeast/hyphal transition in dimorphic fungi. Another consequence of membrane alrerations is the impairment of primary metabolism. All these distortions lead to stasis of cell growth o r the ultimate death o f cells [ I , 101. Scveral cyclic amines and azadecalins have been shown to inhibit A l'-reductase ;IS wcll as AX-A7-isomerase. T h e phenomenon of one compound acting at two different sites can only be explained if the mcchanisms involvcd at these two sites have steps in common. Mechanistic studies indicate that similar carbocationic high-energy intermediates are involved in the enzymic reactions of the A Id-rcductase and AX -A'-isomcrasc [ 11 1.
After having given the state of the art of the research on inhibitors of A"-reductase and Ax -A7-isomerase of fungi, attention will be focused on factors influencing thc antifungal activity and on confirmation of the high-encrgy intcrmcdiate hypothesis.
Fuctors ir~fluencitrg uri t if irrigul uctivity
Chemistry. T h e antimycotic and agrifungicidal activities of cyclic amines are bound to specific structural requirements. Moreover, the stereochemistry proved to hc very important when considering the differences in activity encountered during studics of the antifungal activity of the various isomers 14, 5 ) . Using the enzyme assays for A'%-eductase and A X -A'-isomerase in v i m , it has been proven that the diffcrences in the effect of the various isomers on the growth of various fungi are reflections of the extent of the inhibition of the most sensitive enzyme to the most potent isomer [ I , 101. T h e antibiotic complex A25822 consists of seven structurally similar azasterols. Component A25822B ( 1 S-azamethylene-I~-homocholesta-8,14-dien-3~-ol) proved to be the most important compound in quantity as well as in activity. T h e similarity of the inhibitor to ignosterol is evident.
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